CSL · ASX

CSL Limited (ASX:CSL)

AU$212.89

 0.19 (0.089%)
ASX:Live
29/08/2025 04:17:54 PM
Short Term Trend - Short Hammer Bullish HALO Ords HALO Capital Efficiency HALO 50 +9
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

CSL Overview

CSL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Very Strong

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Neutral

Growth

Earnings

Strong

Dividends

Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About CSL

Website

CSL Limited

Telephone

61.3.9389.1911

Address

655 Elizabeth Street Melbourne, Victoria (VIC) 3000

Description

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.

CSL Price Chart

Key Stats

Market Cap

AU$102.99B

PE

27.20

EV/EBITDA

18.0

Dividends Overview

DIV Yield

1.6%

Franking

N/A

Ex Dividend Date (est.)

09-Sep-25

Market Data

52 weeks range

Low 208.35 - 309.89

Trade Value (12mth)

US$34,803,936.00

1 week

-1.8%

1 month

-21.8%

YTD

-24.35%

1 year

-30.93%

All time high

342.75

Key Fundamentals

EPS 3 yr Growth

28.90%

EBITDA Margin

32.70%

Operating Cashflow

$3,561m

Free Cash Flow Return

12.40%

ROIC

10.50%

Interest Coverage

11.30

Quick Ratio

1.10

Other Data

Shares on Issue (Fully Dilluted)

486m

HALO Sector

Healthcare

Next Company Report Date

18-Aug-26

Ex Dividend Date (est.)

09-Sep-25

Next Dividend Pay Date (est.)

03-Oct-25

Reporting Currency

USD

Short Sell (% of issue)

0.50

CSL Announcements

Latest Announcements

Date Announcements

27 August 25

Notification regarding unquoted securities - CSL

×

Notification regarding unquoted securities - CSL

27 August 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

20 August 25

Notification of buy-back - CSL

×

Notification of buy-back - CSL

19 August 25

CSL Statutory Accounts for FY2025

×

CSL Statutory Accounts for FY2025

19 August 25

CSL FY25 Results and Major Strategic Initiatives

×

CSL FY25 Results and Major Strategic Initiatives

19 August 25

Dividend/Distribution - CSL

×

Dividend/Distribution - CSL

19 August 25

CSL Results Presentation

×

CSL Results Presentation

19 August 25

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

18 August 25

Notice of Investor/Analyst Briefing 2025 Full Year Result

×

Notice of Investor/Analyst Briefing 2025 Full Year Result

05 August 25

Notification of cessation of securities - CSL

×

Notification of cessation of securities - CSL

07 July 25

Notification of cessation of securities - CSL

×

Notification of cessation of securities - CSL

17 June 25

CSL's Andembry FDA Approved

×

CSL's Andembry FDA Approved

10 June 25

Appointment of New Director

×

Appointment of New Director

04 June 25

Notification of cessation of securities - CSL

×

Notification of cessation of securities - CSL

21 May 25

Notification of cessation of securities - CSL

×

Notification of cessation of securities - CSL

08 May 25

Notification of cessation of securities - CSL

×

Notification of cessation of securities - CSL

05 May 25

Shareholder Information Meetings

×

Shareholder Information Meetings

10 April 25

Notification of cessation of securities - CSL

×

Notification of cessation of securities - CSL

03 April 25

CSL Responds to Proposed USA Tariffs

×

CSL Responds to Proposed USA Tariffs

17 March 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

13 March 25

Update - Dividend/Distribution - CSL

×

Update - Dividend/Distribution - CSL

13 March 25

Notification of cessation of securities - CSL

×

Notification of cessation of securities - CSL

11 March 25

Application for quotation of securities - CSL

×

Application for quotation of securities - CSL

11 March 25

Notification regarding unquoted securities - CSL

×

Notification regarding unquoted securities - CSL

05 March 25

Notification regarding unquoted securities - CSL

×

Notification regarding unquoted securities - CSL

CSL Fundamentals

Per Share Records

Historical data

Forecast data

USD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 4.65 5.47 6.20 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 4.64 5.45 6.17 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.2 17.5 13.4 Lock Lock Lock
     PE X Lock Lock Lock Lock 32.9 33.9 27.2 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 21.9 22.3 18.0 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 6.70 8.08 9.14 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.60 1.49 3.27 Lock Lock Lock
     Growth % Lock Lock Lock Lock -6.9 20.6 13.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.3 0.8 2.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 2.44 2.60 2.96 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.8 6.7 13.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.4 1.3 1.6 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 52 48 48 Lock Lock Lock
BPS $ Lock Lock Lock Lock 32.73 35.93 39.93 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -1.37 2.10 6.51 Lock Lock Lock
     Growth % Lock Lock Lock Lock -105.5 253.8 209.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 484 485 486 Lock Lock Lock
Basic m Lock Lock Lock Lock 482 483 484 Lock Lock Lock

Financial Records

Historical data

Forecast data

USD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Income Statement
Sales $m Lock Lock Lock Lock 13,174 14,690 15,430 Lock Lock Lock
     Growth % Lock Lock Lock Lock 25.5 11.5 5.0 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 3,434 3,449 3,507 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 6,367 7,151 7,538 Lock Lock Lock
     Growth % Lock Lock Lock Lock 14.4 12.3 5.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 48.3 48.7 48.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 52 51 51 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 3,764 4,640 5,048 Lock Lock Lock
     Growth % Lock Lock Lock Lock 10.7 23.3 8.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 28.6 31.6 32.7 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 831 938 1,017 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 2,933 3,702 4,031 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.6 26.2 8.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 22.3 25.2 26.1 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 2,663 3,375 3,724 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 419 661 588 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 2,244 2,642 3,002 Lock Lock Lock
     Growth % Lock Lock Lock Lock -0.5 17.7 13.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 17.0 18.0 19.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 2,601 2,764 3,561 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1,692 1,258 998 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -11,843 -1,259 -850 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 456 -1,284 -2,241 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 1,373 1,915 2,925 Lock Lock Lock
     Growth % Lock Lock Lock Lock -11.4 39.5 52.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.1 0.1 0.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 1,548 1,657 2,157 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 36,234 38,022 39,404 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 11,172 11,239 10,694 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 10,679 10,526 9,341 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 18,408 18,621 17,997 Lock Lock Lock
Equity $m Lock Lock Lock Lock 15,952 17,036 19,107 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 26,958 28,602 30,029 Lock Lock Lock
     Growth % Lock Lock Lock Lock 36.6 6.1 5.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 6.2 6.9 7.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 14.1 15.5 15.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 10.8 12.2 12.8 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 9.6 9.7 10.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 11.2 10.1 12.4 Lock Lock Lock

Ratios Records

Historical data

Forecast data

USD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Leverage
Interest Cover X Lock Lock Lock Lock 8.5 9.7 11.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.8 2.3 1.9 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 66.9 61.8 48.9 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.0 2.2 2.5 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.8 1.0 1.1 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 16.7 15.4 18.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 56.4 55.8 74.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 7.7 6.4 5.5 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.4 1.3 1.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 2.8 2.6 2.2 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 6.3 5.8 5.2 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.4 0.4 0.4 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.4 0.4 0.4 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 20.2 23.0 24.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 7.3 8.9 9.5 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 15.7 19.6 15.8 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 6.2 6.9 7.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.3 2.2 2.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 14.1 15.5 15.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 47.5 52.4 52.3 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 6.7 8.1 8.2 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 261.7 271.9 281.5 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 47.6 57.4 66.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 309.3 329.3 347.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 31.7 37.8 35.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 277.6 291.5 312.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

09-Sep-25

DIV Yield

1.6%

Franking Level

N/A

DPSg

13.60%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.64%

Value ($M)

835

Prior Change

N/A

7 Day Change

N/A

1 Month Change

0.20%

3 Month Change

0.20%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CSL Shortsell

Frequently Asked Questions

The current share price of CSL Limited (CSL:ASX) is AU$212.89.
The 52-week high share price for CSL Limited (CSL:ASX) is AU$309.89.
The 52-week low share price for CSL Limited (CSL:ASX)? is AU$208.35.
The current TTM dividend payout for CSL Limited (CSL:ASX) is 1.60.
The last dividend payment of CSL Limited (CSL:ASX) is AU$2.07.
CSL Limited (CSL:ASX) has a franking level of 0.0%.
CSL Limited (CSL:ASX) is classified in the Healthcare.
The current P/E ratio for CSL Limited (CSL:ASX) is 27.20.
The current share price of CSL Limited (CSL:ASX) is AU$212.89.
The 52-week high share price for CSL Limited (CSL:ASX) is AU$309.89.
The 52-week low share price for CSL Limited (CSL:ASX)? is AU$208.35.
The current TTM dividend payout for CSL Limited (CSL:ASX) is 1.60.
The last dividend payment of CSL Limited (CSL:ASX) is AU$2.07.
CSL Limited (CSL:ASX) has a franking level of 0.0%.
CSL Limited (CSL:ASX) is classified in the Healthcare.
The current P/E ratio for CSL Limited (CSL:ASX) is 27.20.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.